VIDEO: Novel therapies for intermediate AMD, Stargardt disease raise hope

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Quan Dong Nguyen, MD, MSc, shares the latest achievements in two areas: intermediate age-related macular degeneration and Stargardt disease.
In patients with intermediate non-neovascular AMD, treatment with photobiomodulation (LumiThera) over a 2-year period showed visual acuity improvement, decreasing the risk of progressing to wet AMD or geographic atrophy.
Stargardt disease is a devastating condition with no treatment. The use of a new drug, tinlarebant (LBS-008, Belite Bio), has demonstrated promising results in

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.